Javascript must be enabled to continue!
MYCOBACTERIUM HAEMOPHILUM AND CRYPTOCOCCUS NEOFORMANS COINFECTION IN A SYSTEMIC LUPUS ERYTHEMATOSUS PATIENT
View through CrossRef
Mycobacterium haemophilum and Cryptococcus neoformans are human pathogens in immunocompromised individuals. They exhibit a diversity of cutaneous manifestations and could cause disseminated infections. Herein, we report a Thai female with an underlying disease of systemic lupus erythematous, end stage renal disease and hypertension who was on immunosuppressive therapy and diagnosed with disseminated M. haemophilum and C. neoformans coinfection. She presented with multiple indurated plaques on her back, oedematous plaques on both legs and feet with nodules and ulcers on her right leg. She was diagnosed by skin biopsy, acid-fast staining, real-time polymerase chain reaction, tissue culture and haemoculture. A combination of rifampicin, macrolide, fluoroquinolone, amikacin and co-trimoxazole were used to cure M. haemophilum infection. Cryptococcosis was treated with amphotericin B and flucytosine for 5 weeks, then followed by fluconazole. We aim to report a unique dermatological manifestation, microbiology, histopathology, and treatment of the disease. Successful diagnosis and multiple antimicrobials agents are key managements for Mycobacterium haemophilum infection and Cryptococcosis.
Title: MYCOBACTERIUM HAEMOPHILUM AND CRYPTOCOCCUS NEOFORMANS COINFECTION IN A SYSTEMIC LUPUS ERYTHEMATOSUS PATIENT
Description:
Mycobacterium haemophilum and Cryptococcus neoformans are human pathogens in immunocompromised individuals.
They exhibit a diversity of cutaneous manifestations and could cause disseminated infections.
Herein, we report a Thai female with an underlying disease of systemic lupus erythematous, end stage renal disease and hypertension who was on immunosuppressive therapy and diagnosed with disseminated M.
haemophilum and C.
neoformans coinfection.
She presented with multiple indurated plaques on her back, oedematous plaques on both legs and feet with nodules and ulcers on her right leg.
She was diagnosed by skin biopsy, acid-fast staining, real-time polymerase chain reaction, tissue culture and haemoculture.
A combination of rifampicin, macrolide, fluoroquinolone, amikacin and co-trimoxazole were used to cure M.
haemophilum infection.
Cryptococcosis was treated with amphotericin B and flucytosine for 5 weeks, then followed by fluconazole.
We aim to report a unique dermatological manifestation, microbiology, histopathology, and treatment of the disease.
Successful diagnosis and multiple antimicrobials agents are key managements for Mycobacterium haemophilum infection and Cryptococcosis.
Related Results
Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus
Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus
Background
Cutaneous involvement is very common in systemic lupus erythematosus. We describe the prevalence and spectrum of lupus-specific (cutaneous lupus eryt...
Mycobacterium haemophilum scleritis: two case reports and review of literature
Mycobacterium haemophilum scleritis: two case reports and review of literature
Abstract
Background
Mycobacterium haemophilum is a rare and emerging nontuberculous mycobacteria (NTM). It normally causes localized or disseminated...
Crucial Role of Foxp3 Gene Expression and Mutation in Systemic Lupus Erythematosus, Inferred from Computational and Experimental Approaches
Crucial Role of Foxp3 Gene Expression and Mutation in Systemic Lupus Erythematosus, Inferred from Computational and Experimental Approaches
The impaired suppressive function of regulatory T cells is well-understood in systemic lupus erythematosus. This is likely due to changes in Foxp3 expression that are crucial for r...
Precision medicine and patient perspectives in systemic lupus erythematosus
Precision medicine and patient perspectives in systemic lupus erythematosus
<p dir="ltr">Systemic lupus erythematosus (SLE) is an autoimmune disease (AID) with diverse clinical presentations and complex immunopathogenesis. Its chronic and variable co...
Precision medicine and patient perspectives in systemic lupus erythematosus
Precision medicine and patient perspectives in systemic lupus erythematosus
<p dir="ltr">Systemic lupus erythematosus (SLE) is an autoimmune disease (AID) with diverse clinical presentations and complex immunopathogenesis. Its chronic and variable co...
Murine natural killer cells are fungicidal to Cryptococcus neoformans
Murine natural killer cells are fungicidal to Cryptococcus neoformans
Murine natural killer (NK) cells have been shown to bind to and inhibit the growth of Cryptococcus neoformans in vitro and to contribute to clearance of the organism in vivo. Howev...
Bacterial coinfections during murine cutaneous leishmaniasis
Bacterial coinfections during murine cutaneous leishmaniasis
Cutaneous leishmaniasis (CL) is a parasitic disease causing chronic, ulcerating skin lesions. Most humans infected with the causative Leishmania protozoa are asymptomatic. Leishman...
BRIEF REVIEW ABOUT NEUROLOGICAL, HEMATOLOGICAL, GASTROINTESTINAL, CARDIOVASCULAR AND PULMONAR MANIFESTATIONS OF SYSTEMIC ERYTHEMATOSUS LUPUS
BRIEF REVIEW ABOUT NEUROLOGICAL, HEMATOLOGICAL, GASTROINTESTINAL, CARDIOVASCULAR AND PULMONAR MANIFESTATIONS OF SYSTEMIC ERYTHEMATOSUS LUPUS
Systemic Lupus Erythematosus is an autoimmune multisystem pathology, characterized by being more prevalent in women, especially African women. One of the most frequent pathologies ...

